APC |
APC regulator of WNT signaling pathway |
ATR |
ataxia telangiectasia and RAd3-related kinase |
BCDX2 complex |
RAD51 paralogs (RAD51B, RAD51C, RAD51D) and XRCC2 |
BMPR1A |
bone morphogenetic protein receptor type 1A |
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
BRCA |
BRCA1 DNA repair associated (alias FANCS) |
BRCA2 |
BRCA2 DNA repair associated (alias FANCD, FANCD1) |
BRIP1 |
BRCA1 interacting helicase 1 (alias FANCJ) |
CHK1 |
checkpoint kinase1 |
CNV |
copy number variation |
CRC |
colorectal cancer |
dNTP |
deoxyribonucleoside triphosphate |
DSB |
double-strand break |
EOCRC |
early-onset CRC |
ERCC1 |
ERCC excision repair 1, endonuclease catalytic subunit |
ERCC4 |
ERCC excision repair 4, endonuclease catalytic subunit (alias FANCQ) |
FA |
Fanconi anemia |
FAAP |
RNA 2′,3′-cyclic phosphate and 5′-OH ligase |
FAAP100 |
FA core complex associated protein 100 |
FAAP20 |
FA core complex associated protein 20 |
FAAP24 |
FA core complex associated protein 24 |
FAN1 |
FANCD2 and FANCI associated nuclease 1 |
FANC |
FA complementation group |
FANCA |
FA complementation group A |
FANCB |
FA complementation group B |
FANCC |
FA complementation group C |
FANCD1 |
BRCA2 DNA repair associated (official symbol BRCA2) |
FANCD2 |
FA complementation group D2 |
FANCE |
FA complementation group E |
FANCF |
FA complementation group F |
FANCG |
FA complementation group G (alias XRCC9) |
FANCI |
FA complementation group I |
FANCJ |
BRCA1 interacting helicase 1 (official symbol BRIP1) |
FANCL |
FA complementation group L |
FANCM |
FA complementation group M |
FANCN |
partner and localizer of BRCA2 (official symbol PALB2) |
FANCO |
RAD51 paralog C (official symbol RAD51C) |
FANCP |
SLX4 structure-specific endonuclease subunit |
FANCQ |
ERCC excision repair 4, endonuclease catalytic subunit (official symbol ERCC4) |
FANCR |
RAD51 recombinase (official symbol RAD51) |
FANCS |
BRCA1 DNA repair associated (official symbol BRCA) |
FANCT |
FA complementation group T/Ubiquitin Conjugating Enzyme E2 T (official symbol UBE2T) |
FANCU |
X-ray repair cross complementing 2 (official symbol XRCC2) |
FANCV |
mitotic arrest deficient 2 like 2 (official symbol: MAD2L2; alias REV7) |
FANCW |
ring finger and WD repeat domain 3 (official symbol RFWD3) |
FCCTX |
familial CRC type X |
FOLFIRI |
fluorouracil/leucovorin, irinotecan |
FOLFOX |
fluorouracil/leucovorin, oxaliplatin |
G4 |
G-quadruplex |
GEO |
Gene Expression Omnibus |
HR |
homologous recombination |
HRR |
homologous recombinational repair |
ICL |
inter-strand crosslink |
ID2 complex |
FANCI-FANCD2 |
KRAS |
Kirsten RAS proto-oncogene |
LARC |
locally advanced rectal cancer |
mCRC |
metastatic CRC |
MEK1 |
mitogen-activated protein kinase kinase 1 (official symbol MAP2K1) |
MEK2 |
mitogen-activated protein kinase kinase 2 (official symbol MAP2K2) |
MHF1 |
centromere protein S (official symbol CENPS) |
MHF2 |
centromere protein X (official symbol CENPX) |
MLH1 |
mutL homolog 1 |
MLH2 |
PMS1 homolog 1, mismatch repair system component (official symbol PMS1) |
MMR |
mismatch repair, |
MRN complex |
MRE11-RAD50-NBS proteins |
MSH2 |
mutS homolog 2 |
MSH6 |
mutS homolog 6 |
MSI |
microsatellite instability |
MSS |
microsatellite stability |
MUTYH |
mutY DNA glycosylase |
NCI GDC |
National Cancer Institute-Genomic Data Commons |
NER |
nucleotide excision repair |
NGS |
next-generation sequencing; |
NHEJ |
non-homologous end joining |
NTHL |
nth like DNA glycosylase |
PALB2 |
partner and localizer of BRCA2 (alias FANCN) |
PARP1 |
poly (ADP-ribose) polymerase 1 |
PARPi |
PARP inhibitor |
PFS |
progression-free survival |
PMS2 |
PMS1 homolog 2, mismatch repair system component |
POLD1 |
DNA polymerase delta 1, catalytic subunit |
POLE |
DNA polymerase epsilon, catalytic subunit |
POLQ |
DNA polymerase theta |
PPAP |
polymerase proofreading–associated polyposis |
PPI |
protein–protein interaction |
PTEN |
phosphatase and tensin homolog |
PV |
pathogenic variation |
RAD51 |
RAD51 recombinase (alias FANCR) |
RAD51B |
RAD51 paralog B |
RAD51C |
RAD51 paralog C (alias FANCO) |
RAD51D |
RAD51 paralog D |
REV1 |
REV1 DNA directed polymerase |
REV7 |
mitotic arrest deficient 2 like 2 (official symbol: MAD2L2; alias FANCV) |
RFWD3 |
ring finger and WD repeat domain 3 (alias FANCW) |
RNaseH |
ribonuclease H |
SMAD4 |
SMAD family member 4 |
ssDNA |
single-strand DNA |
STK11 |
serine/threonine kinase 11 |
TLS |
translesion DNA synthesis |
TMEJ |
polymerase theta-mediated end joining |
TMS |
telomestatin |
TNM |
tumor (lymph) node metastasis staging |
TP53 |
tumor protein p53 |
UBE2T |
Ubiquitin Conjugating Enzyme E2 T (alias FANCT) |
VEGF |
Vascular endothelial growth factor |
WES |
whole-exome sequencing |
XRCC2 |
X-ray repair cross complementing 2 (alias FANCU) |